STEAP1 and prostate cancer: Since STEAP1 has been associated with increased risk of prostate cancer relapse and with a high Gleason score,26,27 this has led to interest in using STEAP1 detection for monitoring metastatic disease28 as well as making it an attractive CAR target in metastatic prostate cancer.